Seeking Alpha HealthcareOriginal article
Iridex reaffirms 2026 revenue guidance of $51m-$53m while highlighting working-capital build tied to headquarters relocation
EarningsNeutral
AI Analysis
Summary
Iridex reaffirmed its 2026 revenue guidance of $51m-$53m while noting working-capital impacts from its headquarters relocation.
Financial Highlights
Guidance
$51m-$53m
Importance:2/10
Sentiment:
0.00
guidance_reaffirmationrevenue_guidanceworking_capitalheadquarters_relocation
Related Companies
Read the original article
Published by Seeking Alpha Healthcare on August 19, 2026 12:02 AM
